Document is current
Any future updates will be listed below
-
Authors
Rana, Sanjana K.
Perkins, Rebecca B.
Carr, Devan
Feldman, Sarah
Welch, Kelly
Duffey-Lind, Eileen
Villa, Alessandro https://orcid.org/0000-0002-1966-6000
-
Funding
Funding for this research was provided by:
National Library of Medicine (UG4LM012347)
- License Information
-
More Information
Article History
Accepted: 17 August 2024
First Online: 5 September 2024
Declarations
:
: DFHCC OHRS IRB Protocol Number:22 − 021; exempt.
: A. Villa: Consultant for the American Cancer Society national HPV vaccination Roundtable, Merck, K Pharmaceuticals, AfyxTherapeutics, LipellaPharmaceuticals, WSK Medical and Primary Endpoint Solutions. He has funded research from Merck, MeiraGtx and Mureva. R. Perkins: Dr. Perkins serves on the American Cancer Society national HPV vaccination Roundtable. E. Duffey-Lind: Serves on the American Cancer Society National Cervical Cancer Roundtable and Team Maureen. K. Welch: Serves on the American Cancer Society HPV Roundtable and Team Maureen.
